scispace - formally typeset
O

Otmar Pachinger

Researcher at Innsbruck Medical University

Publications -  192
Citations -  6326

Otmar Pachinger is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 44, co-authored 191 publications receiving 6000 citations. Previous affiliations of Otmar Pachinger include University of Innsbruck.

Papers
More filters
Journal ArticleDOI

HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

TL;DR: Findings support the concept that statins have antiinflammatory and antiproliferative effects that are relevant in the treatment of atherosclerotic diseases.
Journal ArticleDOI

Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia Role of Asymmetric Dimethylarginine

TL;DR: It is suggested that experimental hyperhomocyst(e)inemia leads to accumulation of the endogenous NO synthase inhibitor ADMA, accompanied by varying degrees of endothelial dysfunction according to the preexisting state of cardiovascular health.
Journal ArticleDOI

Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.

TL;DR: In this paper, the authors measured brain natriuretic peptide (BNP), NT-proBNP, and Pro-atrial natriive peptide(NT-proANP) for the detection of heart failure.
Journal ArticleDOI

Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells.

TL;DR: The data indicate that HO-1 activity influences the generation of VEGF in VSMC in both normoxic and hypoxic conditions, and indicates that CO and iron, respectively the inducer and the inhibitor of V EGF synthesis, are concomitantly produced during the degradation of heme.
Journal ArticleDOI

Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF.

TL;DR: These studies reveal that NO derived from NO-donors or generated by NOS within the cells, upregulates the synthesis of VEGF in vascular smooth muscle cells, an alternative approach in therapeutic angiogenesis.